Amgen Is Said to Agree to Buy Horizon at $26 Billion Valuation
Amgen Inc. has agreed to buy Horizon Therapeutics Plc at a valuation of about $26 billion in what would be its biggest-ever acquisition, according to a person familiar with the matter.
Monday, December 12, 2022 at 6:24 am